2020 Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency
Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.
2019 Annual Report
2019 was a year of significant progress against HIV, tuberculosis (TB), and hepatitis C virus (HCV). We shaped policy and legislation to end these conditions, secured increased funding to do so at various levels of government, and stood up for the rights of affected communities.
Treatment Action Group Mourns and Resists Violence towards Black Communities; Demands Action and Accountability across Government and Systems
Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.
SARS-CoV-2 Serological Testing: What Is It and What Does It Mean?
ICAP at Columbia, TAG, and the COVID-19 Working Group – New York presented this webinar on May 13, 2020.
AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies
The COVID-19 pandemic is a global health emergency that may demand new, safe, and expedited ways of conducting ethical research to find the solutions we need, including a safe and effective vaccine.
TAGline May 2020
Realizing the Right to Science: When we started to put together this issue of TAGline, we had no idea that COVID-19 was about to make its appearance and wreak havoc on every country of the world.
Treatment Action Group and the PrEP4All Collaboration Respond to Reported Remdesivir Results for COVID-19
Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...
Open Letter to the Diagnostics Supply Consortium
On 24 April 2020, advocates sent an open letter to the Diagnostics Supply Consortium calling for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to molecular diagnostic testing for COVID-19...
Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis
AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.